Asia Pacific Needle-Free Injection Systems Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-

Asia Pacific Needle-Free Injection Systems Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle-free Injectors, Projectile-based Needle-free Injectors, and Powder-Based Needle-free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)

The Asia Pacific Needle-Free Injection Systems Market is expected to grow from US$ 32.68 million in 2022 to US$ 89.30 million by 2028; it is estimated to grow at a CAGR of 18.2% from 2022 to 2028.

Development of New Technologies for Needle-Free Injection System s to Bolster Asia Pacific Needle-Free Injection Systems Market during Forecast Period

Parenteral is often considered the default drug delivery route but is also an implausible process. Increasing the use of innovative technologies such as the use of artificial intelligence (AI), bar code identification (BI), telecare, and e-prescription can help clinicians and pharmacists in many ways by allowing the storage of patient planned proceedings and patient records and smoothening the vaccination process. As a result, many pharmaceutical manufacturers have embraced IT technology owing to the various benefits of automated IT and provide painless and effective drug delivery systems that can benefit the patients. For instance, Nemera developed a customizable platform—Safe’n’Sound. It is an add-on passive safety device for a prefilled syringe that is aimed at preventing potential needlestick injuries by stimulating a feature that automatically activates at the end of the injection and simplifies the injection process. Healthcare workers had to deal with various challenges due to NSIs, but the burden of these injuries has reduced with the changing technology. A few of the key players operating in the needle-free injection systems market such as Portal Instruments and PharmaJet are focusing on developing innovative products such as micro-array patches, digital needle free injectors, and wearable needle free insulin injectors to deal with issues related to outmoded challenges related to breakage, leakage, and needlestick prevention. Thus, with the surge in new technologies, the demand for needle-free injection systems are expected to grow during the forecast period.

Market Overview

The Asia Pacific needle-free injection systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 21.16% of the global needle-free injection systems market in 2022, owing to the increasing prevalence rate of chronic diseases, rising healthcare expenditure, and growing communicable diseases due to the increasing needlestick injuries. Moreover, an increase in company initiatives for research and development, high technological advancements, and a rise in the focus of market players in emerging economies for the development of innovative products are expected to boost the growth of the Asia Pacific needle-free injection system market during the forecast period.

Asia Pacific Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Needle-Free Injection Systems Market Segmentation

The Asia Pacific needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the Asia Pacific needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.

Based on technology, the Asia Pacific needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.

Based on type, the Asia Pacific needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.

Based on durability, the Asia Pacific needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.

Based on site of delivery, the Asia Pacific needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.

Based on application, the Asia Pacific needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.

Based on end user, the Asia Pacific needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.

Based on country, the Asia Pacific needle-free injection systems market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.

Aijex Pharma International Inc., Crossject, Ferring B.V., Medical International Technologies (MIT Canada) Inc., NuGen Medical Devices, and Zealand Pharma A/S are the leading companies operating in the needle-free injection systems market in Asia Pacific.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific needle-free injection systems market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution